Editorial Comment
Editorial Comment on “Association between antibiotic use and subsequent risk of prostate cancer: A retrospective cohort study in South Korea”
-
Association between antibiotic use and subsequent risk of prostate cancer: A retrospective cohort study in South Korea
- Sun Jae Park,
- Jaeyi Hong,
- Young Jun Park,
- Seogsong Jeong,
- Seulggie Choi,
- Jooyoung Chang,
- Yun Hwan Oh,
- Minjung Han,
- Ahryoung Ko,
- Sugyeong Kim,
- Yoosun Cho,
- Ji Soo Kim,
- Joung Sik Son,
- Sang Min Park,
- Volume 31Issue 4International Journal of Urology
- pages: 325-331
- First Published online: December 21, 2023
First published: 12 January 2024
No abstract is available for this article.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflict of interest.
REFERENCES
- 1Hatano K, Nonomura N. Genomic profiling of prostate cancer: an updated review. World J Mens Health. 2022; 40: 368–379.
- 2Fujita K, Matsushita M, Banno E, de Velasco MA, Hatano K, Nonomura N, et al. Gut microbiome and prostate cancer. Int J Urol. 2022; 29: 793–798.
- 3Matsushita M, Fujita K, Motooka D, Hatano K, Fukae S, Kawamura N, et al. The gut microbiota associated with high-Gleason prostate cancer. Cancer Sci. 2021; 112: 3125–3135.
- 4Matsushita M, Fujita K, Hayashi T, Kayama H, Motooka D, Hase H, et al. Gut microbiota-derived short-chain fatty acids promote prostate cancer growth via IGF1 signaling. Cancer Res. 2021; 81: 4014–4026.
- 5Park SJ, Hong J, Park YJ, Jeong S, Choi S, Chang J, et al. Association between antibiotic use and subsequent risk of prostate cancer: a retrospective cohort study in South Korea. Int J Urol. 2024; 31: 325–332.
